Abstract. Effects 
TSH, prolactin (Prl) , GH, LH, FSH, T3, T4, calcitonin, parathyroid hormone (PTH), insulin, plasma renin activity (PRA), aldosterone and testosterone levels were measured at \m=-\15, 0,30, 120, 240 min and 24, 48, 72 and 96 h after the infusion. During the first 240 min Prl and GH levels showed an increase that was thought to be either an effect of release of hormones or a consequence of stress. At the same time the thyroid hormones, T3, T4 and calcitonin decreased, presumably owing to an alteration in the blood flow to the thyroid gland. All these hormone levels returned to normal at 24 h in spite of the infusion continuing. PRA increased only during the second half of the infusion. No (Szczeklik et al. 1979; Hossmann et al. 1981) , ischaemic stroke (Gryglewski et al. 1983 ), pulmonary hypertension (Watkins et al. 1980; Higgenbottam et al. 1984 ), Raynaud's phenomenon (Dowd et al. 1982) , and extracorporal circulation (Coppe et al. 1981; Ditteretal. 1983) .
Since a widespread use of PGI2 either in the form of continuous iv infusion or oral tablets is expected, the endocrinological effects of the drug must be explored too. PGI2 increases the TSH and Prl levels in vitro (Wright & Hedge 1981) , but shows no effects on the isolated adrenal gland cells (Layhock 1979 ). An increase in the Prl and a decrease in the LH levels has been observed in rats (Kimball et al. 1979 Figs. 1-3) .
Results
The concentrations of Prl showed a significant increase at 120 and 240 min and decreased slowly to normal, despite the unaltered circumstances of the infusion (Fig. 1) . The GH level increased at 30
and 120 min and returned to normal faster (Fig. 1) .
No significant changes were found in the ACTH, TSH, LH and FSH levels and the cortisol levels did not increase. T3 and T4 levels decreased signifi¬ cantly at 120 min, whereas at 24 h a moderate rebound was observed (Fig. 2) . (Allolio et al. 1980; Ylikorkala et al. 1982) .
What points against this is that the other 'stress hormones', for instance cortisol and ACTH, re¬ mained unchanged. In the reported short-term experiments the dose of PGI2 was between 8 and 20 ng/kg/min. We used 5 ng/kg/min, which is sufficient for clinical pur¬ poses (Szczeklik et al. 1979; Blaskó et al. 1980; Hossmann et al. 1981 (1981) .
The decrease in the thyroid hormone levels in¬ cluding calcitonin could raise the question whether it could be the consequence of a decreased thyroid perfusion. Similarly, the increases in Prl and GH could be a consequence of the alterations in circula¬ tion and dopamine levels in the hypothalamus. However, the latter suggestion is not supported by experiments performed in rats (Brus et al. 1981 
